Utibron Neohaler is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD). Utibron Neohaler is a combination drug composed of Indacaterol and Glycopyrrolate.

Indacaterol is a long-acting beta-adrenoceptor agonist (LABA). Glycopyrrolate is an anticholinergic. Both drugs are long-acting bronchodilators. Both drugs are believed to work by relaxing and dilating the airways, making it easier to breathe.

How do I take it?
Utibron Neohaler is taken twice daily.

Utibron Neohaler comes in the form of powder capsules to be taken w... read more

Utibron Neohaler (Indacaterol/Glycopyrrolate) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in